Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
12

Summary

Conditions
  • Chronic Lymphocytic Leukemia
  • Richter Syndrome
Type
Interventional
Phase
Phase 1Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02535286
Collaborators
Memorial Sloan Kettering Cancer Center
Investigators
Study Chair: Anthony R. Mato, MD Memorial Sloan Kettering Cancer Center